Form 4: Alkermes VP Parisi Reports Share Sale, New Equity Awards

Samuel Joseph Parisi, VP of Finance at Alkermes plc, disclosed the sale of ordinary shares under a pre-arranged trading plan and the acquisition of new employee stock options and restricted stock units.

Summary

• Samuel Joseph Parisi, VP, Finance (Interim PAO) of Alkermes plc (ALKS), reported changes in his beneficial ownership.
• Parisi sold 6,890 ordinary shares at a price of $29.29 per share on March 2, 2026.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted on November 7, 2025.
• Parisi acquired 15,033 employee stock options with an exercise price of $30.25 on March 2, 2026.
• He also acquired 14,176 restricted stock unit (RSU) awards on March 2, 2026, where each RSU represents a contingent right to receive one ordinary share.
• Following these transactions, Parisi directly owns 7,717 ordinary shares, 15,033 employee stock options, and 14,176 restricted stock unit awards.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While there was a share sale, it was pre-planned, and the executive also received significant new equity awards, indicating continued alignment with the company's long-term performance.

Positives

• Acquisition of 15,033 employee stock options, providing potential future equity upside.
• Acquisition of 14,176 restricted stock unit awards, aligning executive interests with shareholder value through future share grants.

Negatives

• Sale of 6,890 ordinary shares, reducing direct equity ownership in the company.

Future Outlook

The acquired employee stock options and restricted stock units are subject to a four-year vesting schedule, with the first installment commencing on March 2, 2027, indicating a long-term incentive structure for the executive. The employee stock options have an expiration date of March 2, 2036.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing insider transactions, including sales under Rule 10b5-1 plans and the granting of equity awards, are routine disclosures for publicly traded companies. These transactions reflect standard executive compensation practices and pre-planned liquidity events, rather than immediate reactions to company performance.

Stakeholder Impact

• Shareholders: The sale of shares by an executive could be perceived negatively, but the pre-planned nature (10b5-1) mitigates concerns. The new equity awards align the executive's long-term interests with shareholder value.
• Employees: Standard executive compensation practices, including equity awards, are common and generally do not directly impact other employees beyond setting a precedent for incentive structures.

Next Steps

• Vesting of 15,033 employee stock options in four equal annual installments, commencing March 2, 2027.
• Vesting of 14,176 restricted stock unit awards in four equal annual installments, commencing March 2, 2027.

Key Dates

Keywords

Alkermes, ALKS, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Rule 10b5-1, Beneficial Ownership, Executive Compensation